Search Tag: microvascular invasion
2025 09 Nov
Hepatocellular carcinoma (HCC) continues to drive significant morbidity and mortality. Microvascular invasion (MVI) is a key marker of aggressive biology, yet confirmation usually arrives only after surgery. An MRI-based approach now captures how uneven the tumour and its immediate surroundings appear on routine sequences, turning those patterns...Read more
2025 02 Sep
Microvascular invasion is a key histopathological feature linked to recurrence and poor survival in hepatocellular carcinoma, yet it is confirmed only after surgery, limiting its value for preoperative decision-making. A retrospective multicentre analysis of 655 surgically confirmed cases explored whether three-dimensional fractal dimension derived...Read more
2025 02 Sep
Microvascular invasion is a key histopathological feature linked to recurrence and poor survival in hepatocellular carcinoma, yet it is confirmed only after surgery, limiting its value for preoperative decision-making. A retrospective multicentre analysis of 655 surgically confirmed cases explored whether three-dimensional fractal dimension derived...Read more
2025 06 Jul
Hepatocellular carcinoma (HCC) is a major global health burden and ranks among the leading causes of cancer-related deaths. Despite curative treatments such as liver resection or transplantation, HCC exhibits high recurrence rates, often due to microvascular invasion (MVI), a pathological hallmark of tumour aggressiveness. Accurate preoperative...Read more
2025 01 Jul
Hepatocellular carcinoma (HCC) is a prevalent malignancy and a leading cause of cancer-related mortality worldwide. Despite curative interventions like hepatectomy and liver transplantation, recurrence rates remain high, with microvascular invasion (MVI) serving as a critical prognostic marker. Current methods to determine MVI rely on postoperative...Read more
2025 01 Jul
Hepatocellular carcinoma (HCC) is a prevalent malignancy and a leading cause of cancer-related mortality worldwide. Despite curative interventions like hepatectomy and liver transplantation, recurrence rates remain high, with microvascular invasion (MVI) serving as a critical prognostic marker. Current methods to determine MVI rely on postoperative...Read more
2024 03 Nov
Microvascular invasion (MVI) in hepatocellular carcinoma (HCC) poses significant challenges in the treatment and management of patients. MVI is a histological feature indicative of tumour cells infiltrating blood vessels near the primary tumour. This feature is closely associated with increased recurrence rates and poorer outcomes post-surgery....Read more